Skip to main content
$0.015 (0%)

High

$0.02

Low

$0.02

Trades

21

Turnover

$27,023

Volume

1,798,203
30 June 2023 at 2:47pm
If you were already registered, log in here.

Short Interest

ASIC data, 17 Dec 2020

% Shorted

0.01%
vs 0.01% prior report

Most Shorted Rank

538th
of 711 shorted ASX stocks

Peak Short

0.16%
Nov 2017

Days to Cover

0.1
at 50d avg vol
Subject
LCT Ann: Appendix 4G and Corporate Governance Statement

LCT Ann: Annual Report to Shareholders

LCT Ann: NEW 2022 Annual General Meeting Date

LCT Ann: 2022 Annual General Meeting Date

LCT Ann: New milestone for LCT's AI development

LCT Ann: Becoming a substantial holder

LCT Ann: Receipt of Section 249D Notice

LCT Ann: Change of Director's Interest Notice - R Willcocks

LCT Ann: Notification regarding unquoted securities - LCT

LCT Ann: Notification of cessation of securities - LCT

LCT Ann: Preliminary Final Report and 2022 Financial Statements

LCT Ann: NTCELL Update - Choroid plexus tissue shipped to Sydney

LCT Ann: Quarterly Activity Report and Appendix 4C

LCT Ann: Change of Director's Interest Notice - B Tuch and A Kelly

LCT Ann: Ceasing to be a substantial holder

LCT Ann: NTCELL -Investor Presentation

LCT Ann: LCT Presenting at Gold Coast Investment Showcase

LCT Ann: Change of Director's Interest Notice - C Sue

LCT Ann: Change of Director's Interest Notice - R Willcocks

LCT Ann: Cleansing Notice

LCT Ann: Application for quotation of securities - LCT

LCT Ann: Proposed issue of securities - LCT

LCT Ann: LCT Completes Strategic A$1.285M Placement

LCT Ann: Trading Halt

LCT Ann: Artificial Intelligence to advance NTCELL Production

LCT Ann: Application for quotation of securities - LCT

LCT Ann: LCT Newsletter - May 2022

LCT Ann: Quarterly Activity Report and Appendix 4C

LCT Ann: Cleansing Notice

LCT Ann: Proposed issue of securities - LCT

LCT Ann: Results of General Meeting

LCT Ann: Investor Presentation

LCT Ann: Chairman's Address to the General Meeting

LCT Ann: LCT signs Research Agreement with UTS

LCT Ann: Notice of General Meeting/ Proxy Form

LCT Ann: Funding Update-LCT Advancing NTCELL with Investor Backing

LCT Ann: Investor Presentation

LCT Ann: Investor Webinar

LCT Ann: Change of Address

LCT Ann: LCT Interim CEO Term Extended as NTCELL Advances

LCT Ann: Half Yearly Report and Accounts

LCT Ann: Quarterly Activity Report and Appendix 4C

LCT Ann: LCT Signs Service Agreement with NZeno

LCT Ann: Update - Application for quotation of securities - LCT

LCT Ann: Application for quotation of securities - LCT

LCT Ann: Results of Rights Issue

LCT Ann: Update - Appendix 2A- Issue of shares and Options

LCT Ann: Notification of cessation of securities - LCT

LCT Ann: Application for quotation of securities - LCT

LCT Ann: LCT Appoints COO to Establish NTCELL Trial

If you were already registered, log in here.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX
S88
MAV
ATW $7.5m raise
RDO $30m raise
ABC $5m raise
RGS
MBM